Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation

Providing the sole "no" vote on the approval of Rexulti, the consumer representative on the FDA's advisory committee shares her reasoning.

Related Keywords

United States ,Kim Witczak ,Chris Schott ,Rexulti Brexpiprazole ,Cnn ,Lundbeck ,Psychopharmacologic Drugs Advisory Committee ,Advisory Committee ,Central Nervous System Drugs Advisory Committee ,Lundbeck Pharmaceutical ,Consumer Representative ,Psychopharmacologic Drugs Advisory ,Senior Analyst ,Healthcare Conference ,Has Been ,Adverse Events ,Special Interest ,